Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Interpack 2014: Sterile and Ready to Use Packaging by SCHOTT

Published: Thursday, May 08, 2014
Last Updated: Thursday, May 08, 2014
Bookmark and Share
SCHOTT’s sterile, ready to use vials adaptiQ™ will be on display at Interpack.

At Interpack 2014, SCHOTT will be demonstrating how close cooperation with leading machine manufacturers such as Bausch+Stroebel, Bosch Packaging Technology and OPTIMA can culminate in flexible, new packaging solutions.

SCHOTT discusses its innovative product ideas with these machine manufacturers already during the development phase. The mutual customers - pharmaceutical companies - therefore benefit from an integrated, highly efficient filling process in which the primary packaging and filling lines are perfectly tuned to each other.

With the sterile, ready to use vials adaptiQ™ that will be on display at Interpack, the partners will be catering to one of the most important trends in the pharmaceutical industry: flexible manufacturing strategies that allow for different substance-packaging configurations to be filled efficiently.

adaptiQ will be on exhibit at SCHOTT’s booth (hall 7a, B01) and its partners’ booths at Interpack. The system consists of a so-called nest and tub configuration in which up to 100 ready to use pharmaceutical vials are securely fixed inside the nest in sterile packaging for delivery to the pharmaceutical companies. They can then fill the vials immediately on their filling lines without having to wash or sterilize them first. In fact, they can even fill them on the lines that are normally used to fill nested syringes.

In order to keep the set-up times for changing packaging as short as possible, adaptiQ is orientated towards the proven tub format used in syringe manufacturing. This means pharmaceutical companies can use the same production line for various types of containers and formats after making only minor adjustments.

Although it is embedded in a standard tub, the SCHOTT adaptiQ solution features a nest design that offers advantages over all of the other ready-to-use solutions commonly available today: The vials are held by the neck in the adaptiQ nest and can be lifted or pulled out together inside the nest, to weigh or close them, for example.

Furthermore, the bottom is freely accessible and this ensures just the right temperature transition during lyophilization in particular. For the first time ever, all of the process steps can be performed without having to remove the vials from the nest.

SCHOTT will offer adaptiQ in the common 2R and 4R ISO formats to start with at the end of 2014. The company is already preparing to expand its portfolio rather quickly.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,100+ scientific posters on ePosters
  • More Than 4,500+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

SCHOTT Launches New Center of Excellence for RTU Pharma Packaging
Initiative will more closely tie together SCHOTT’s experts and pharma partners as production of adaptiQ® ready-to-use vials commences.
Saturday, October 24, 2015
Scientific News
The Rise of 3D Cell Culture and in vitro Model Systems for Drug Discovery and Toxicology
An overview of the current technology and the challenges and benefits over 2D cell culture models plus some of the latest advances relating to human health research.
Grant Supports Project To Develop Simple Test To Screen For Cervical Cancer
UCLA Engineering announces funding from Bill and Melinda Gates Foundation.
Injecting New Life into Old Antibiotics
A new fully synthetic way to make a class of antibiotics called macrolides from simple building blocks is set to open up a new front in the fight against antimicrobial drug resistance.
Insight into Bacterial Resilience and Antibiotic Targets
Variant of CRISPR technology paired with computerized imaging reveals essential gene networks in bacteria.
Advancing Protein Visualization
Cryo-EM methods can determine structures of small proteins bound to potential drug candidates.
Alzheimer’s Protein Serves as Natural Antibiotic
Alzheimer's-associated amyloid plaques may be part of natural process to trap microbes, findings suggest new therapeutic strategies.
Slime Mold Reveals Clues to Immune Cells’ Directional Abilities
Study from UC San Diego identifies a protein involved in the directional ability of a slime mold.
How Do You Kill A Malaria Parasite?
Drexel University scientists have discovered an unusual mechanism for how two new antimalarial drugs operate: They give the parasite’s skin a boost in cholesterol, making it unable to traverse the narrow labyrinths of the human bloodstream. The drugs also seem to trick the parasite into reproducing prematurely.
Illuminating Hidden Gene Regulators
New super-resolution technique visualizes important role of short-lived enzyme clusters.
Supressing Intenstinal Analphylaxis in Peanut Allergy
Study from National Jewish Health shows that blockade of histamine receptors suppresses intestinal anaphylaxis in peanut allergy.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,100+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,500+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!